InvestorsHub Logo
Followers 22
Posts 1834
Boards Moderated 0
Alias Born 10/11/2015

Re: hnbadger1 post# 390774

Thursday, 12/08/2022 6:36:32 PM

Thursday, December 08, 2022 6:36:32 PM

Post# of 470772

I still have a hard time believing Dr M would stick to his guns even at the CC if he didn’t believe it. He even said things like “ results are better than expected “
He surely knows the seriousness to the company if not true.
I’m in shock that this is happening.



Exactly, TGD has too much experience and too much education on his resume to play games with data. The truth shall out in the upcoming weeks.

As reported at CTAD, AVXL's blarcamesine is 40% better than any competitive AD drug.

Yes, it hurts to see the naysayers successfully deliver blow after blow without evidence to refute TGD's CTAD headline of meeting all endpoints.

Yes, it's difficult to see 60 million shares plus (approx. 75%) churned since CTAD which combined initially with HUGE put option hedging in the first few days, succeed in knocking AVXL share price down approx. 35%.

But notice the reduction in share and put activity the last 2 days. This share price attack is winding down.

Look for a major price rebound in the next few weeks as AVXL releases "real news" supporting their CTAD headline
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News